Type 1 diabetes autoantigen-specific T-cell receptor (T1D autoantigen-specific TCR)

Type 1 diabetes (T1D) autoantigen-specific T-cell receptors (TCRs) are specialized protein complexes found on the surface of T lymphocytes that recognize specific peptides derived from pancreatic beta-cell proteins, such as insulin, glutamic acid decarboxylase 65 (GAD65), and zinc transporter 8 (ZnT8). These receptors are the primary drivers of T1D pathogenesis, as they allow autoreactive CD4+ and CD8+ T cells to identify and destroy insulin-producing cells when these antigens are presented by major histocompatibility complex (MHC) molecules (Nakayama et al., 2005, Nature). While effector T cells utilize these TCRs to mediate beta-cell destruction, regulatory T cells (Tregs) expressing autoantigen-specific TCRs are essential for maintaining immune homeostasis and suppressing pathogenic autoimmunity (Hull et al., 2017, Journal of Autoimmunity). Therapeutic strategies targeting these TCRs aim to selectively modulate the immune response without causing broad systemic immunosuppression. This includes the use of monoclonal antibodies like Teplizumab, which targets the CD3 component of the TCR complex to exhaust or deplete autoreactive effector cells, and antigen-specific immunotherapies designed to induce tolerance (Herold et al., 2019, NEJM). Emerging approaches also involve engineering Tregs with specific TCRs (TCR-T) to enhance their ability to suppress inflammation directly within the pancreatic environment (Michels, 2015, Therapeutic Advances in Endocrinology and Metabolism). Monitoring these TCRs via MHC-peptide tetramers serves as a critical biomarker for disease progression and therapeutic efficacy.

Other names

Autoreactive T-cell receptorInsulin-specific T-cell receptorGAD65-specific T-cell receptorBeta-cell specific T-cell receptorDiabetogenic T-cell receptorProinsulin-specific T-cell receptor

Modulation of T-cell receptor signaling, induction of antigen-specific anergy or deletion of autoreactive clones, and expansion of antigen-specific regulatory T cells to restore immune tolerance.